PTPRC and cancer: The results concerning other studied CD molecules as CD3 or CD19 and CD45 (data not shown) were no significant in all treated cancers; in the case of CD4 slightly decreased values were registered (as only two cases of each tumour were studied, these observations not be statistically valuable).